Latest Stem cell Stories

LAS VEGAS, Dec. 20, 2012 /PRNewswire/ -- Hemp, Inc. is proud to announce the naming of BioSwan, Inc., a new spin-off of Hemp, Inc., dedicated to improving the quality of life via its proprietary all natural formulations and modalities designed to increase the body's production of pluripotent adult stem cells. Hemp, Inc. has agreed to spin the company off and to retain a two-year exclusive contract for marketing the herbal blends that have been shown to increase the body's production...

Connie K. Ho for redOrbit.com – Your Universe Online Researchers from the Columbia University Medical Center (CUMC) and the New York Stem Cell Foundation (NYSCF) have been able to create a new technique that limits inherited disorders in children. The ability of scientists to transfer the nucleus of a cell from one human egg cell to another was considered an important achievement, and results of the study were recently published in the online edition of Nature. In particular, the...

A new study published in Nature shows how mitochondrial disease may be prevented NEW YORK, Dec. 19, 2012 /PRNewswire-USNewswire/ -- A joint team of scientists from The New York Stem Cell Foundation (NYSCF) Laboratory and Columbia University Medical Center (CUMC) has developed a technique that may prevent the inheritance of mitochondrial diseases in children. The study is published online today in Nature. Dieter Egli, PhD, and Daniel Paull, PhD, of the NYSCF Laboratory with Mark...

University of Sheffield Randomly distributed sticky spots which are integral to the development of stem cells by maximizing adhesion and acting as internal scaffolding have been artificially recreated by experts from the University of Sheffield for the first time. Using synthetic foam type materials to mimic the natural process – known as the extracellular matrix or ECM – scientists, from the University of Sheffield and University of California San Diego, created the random...

BOTHELL, Wash., Dec. 12, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract media manufacturer, today announced that its customer TiGenix NV (Euronext Brussels: TIG) has completed a phase I clinical safety trial of its expanded adipose-derived stem cell platform incorporating BioLife's cGMP HypoThermosol...

MADISON, Wis., Dec. 12, 2012 /PRNewswire/ -- Cellular Dynamics International (CDI), a leading commercial producer of human induced pluripotent stem cell (iPSC) lines and tissue cells, today announced the publication of research demonstrating the use of human iPSC-derived iCell® Neurons to model Alzheimer's disease (AD) and how they may be used in high throughput drug screening. This research was performed by the lab of Zhong Zhong, Ph.D., head of discovery in the regenerative...

NEW YORK, Dec. 10, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announced today that Dr. Harry Fisch has joined the Board of Scientific Advisors and will head up the new Urology Department at IntelliCell. IntelliCell's Chairman and CEO, Dr. Steven Victor stated, "Our Company is very pleased to announce today that Dr. Fisch is joining our Advisory Board and will be the Director of Urology for IntelliCell. He is a pioneering surgeon and respected on the...

Despite treatment with imatinib, a successful drug that targets chronic myeloid leukemia (CML), a deadly type of cancer, some patients may continue to be at risk for relapse because a tiny pool of stem cells is resistant to treatment and may even accumulate additional genetic aberrations, eventually leading to disease progression and relapse. These leukemia stem cells are full of genetic errors, loaded with potentially lethal breaks in DNA, and are in a state of constant self-repair. Now,...

ROCKVILLE, Md., Dec. 10, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Jonathon Glass, MD, Director of the Emory ALS Center, presented new data from the Phase I trial of Neuralstem's human spinal cord stem cells, NSI-566, in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at the International Symposium on ALS/MND in Chicago, sponsored by the Motor Neurone Disease Association. In a Thursday presentation, "RESULTS OF PHASE 1 TRIAL OF SPINAL CORD...

BILLERICA, Mass., Dec. 7, 2012 /PRNewswire/ -- Seahorse Bioscience, the world leader in instrumentation and assay kits for measuring cell metabolism announces travel award recipients who presented at the Asia Mito 2012 Conference, November 2-5, 2012, in Beijing. Yu Ting Wu, Ph.D., candidate at the Institute of Biochemistry and Molecular Biology, National Yang-Ming University, in Taipei, Taiwan. Poster title: Regulation of Mitochondrial FoF1ATPase Activity by Sirt3-catalyzed...